Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PATH | XNGSY |
|---|---|---|
| Price | $13.16 | $24.78 |
| Change today | ▲ 0.30% | ▲ 0.12% |
| Market cap | $6.86B | $6.86B |
| Return, 3 months | +13.0% | +16.5% |
| Return, year to date | -19.7% | -27.0% |
| Return, 1 year | -9.4% | -21.0% |
| P/E (TTM) | 19.6 | 7.8 |
| P/B | 3.5 | 1.0 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 6.21% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 44 | 47 |
| 30-day volatility | 74.4% | 25.5% |
| Max drawdown, 1 year | -51.4% | -43.2% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
